Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;15(2):159–166. doi: 10.1111/j.1750-3639.2005.tb00513.x

Neuroprotectin D1 (NPD1): A DHA‐Derived Mediator that Protects Brain and Retina Against Cell Injury‐Induced Oxidative Stress

Nicolas G Bazan 1,✉
PMCID: PMC8095981  PMID: 15912889

Abstract

The biosynthesis of oxygenated arachidonic acid messengers triggered by cerebral ischemia‐reperfusion is preceded by an early and rapid phospholipase A2 activation reflected in free arachidonic and docosahexaenoic acid (DHA) accumulation. These fatty acids are released from membrane phospholipids. Both fatty acids are derived from dietary essential fatty acids; however, only DHA, the omega‐3 polyunsaturated fatty acyl chain, is concentrated in phospholipids of various cells of brain and retina. Synaptic membranes and photoreceptors share the highest content of DHA of all cell membranes. DHA is involved in memory formation, excitable membrane function, photoreceptor cell biogenesis and function, and neuronal signaling, and has been implicated in neuroprotection. In addition, this fatty acid is required for retinal pigment epithelium cell (RPE) functional integrity. Here we provide an overview of the recent elucidation of a specific mediator generated from DHA that contributes at least in part to its biological significance. In oxidative stress‐challenged human RPE cells and rat brain undergoing ischemia‐reperfusion, 10,17S‐docosatriene (neuroprotectin D1, NPD1) synthesis evolves. In addition, calcium ionophore A23187, IL‐1β, or the supply of DHA enhances NPD1 synthesis. A time‐dependent release of endogenous free DHA followed by NPD1 formation occurs, suggesting that a phospholipase A2 releases the mediator's precursor. When NPD1 is infused during ischemia‐reperfusion or added to RPE cells during oxidative stress, apoptotic DNA damage is down‐regulated. NPD1 also up‐regulates the anti‐apoptotic Bcl‐2 proteins Bcl‐2 and BclxL and decreases pro‐apoptotic Bax and Bad expression. Moreover, NPD1 inhibits oxidative stress‐induced caspase‐3 activation. NPD1 also inhibits IL‐Iβ‐stimulated expression of COX‐2. Overall, NPD1 protects cells from oxidative stress‐induced apoptosis. Because photoreceptors are progressively impaired after RPE cell damage in retinal degenerative diseases, understanding of how these signals contribute to retinal cell survival may lead to the development of new therapeutic strategies. Moreover, NPD1 bioactivity demonstrates that DHA is not only a target of lipid peroxidation, but rather is the precursor to a neuroprotective signaling response to ischemia‐reperfusion, thus opening newer avenues of therapeutic exploration in stroke, neurotrauma, spinal cord injury, and neurodegenerative diseases, such as Alzheimer disease, aiming to up‐regulate this novel cell‐survival signaling.

Full Text

The Full Text of this article is available as a PDF (313.0 KB).

REFERENCES

  • 1. Anderson RE, Maude MB, Bok D (2001) Low docosahexaenoic acid levels in rod outer segment membranes of mice with rds/peripherin and P216L peripherin mutations. Invest Ophthalmol Vis Sci 42:1715–1720. [PubMed] [Google Scholar]
  • 2. Anderson RE, Maude MB, McClellan M, Matthes MT, Yasumura D, LaVail MM (2002) Low docosahexaenoic acid levels in rod outer segments of rats with P23H and S334ter rhodopsin mutations. Mol Vis 8:351–358. [PubMed] [Google Scholar]
  • 3. Aveldano MI, Bazan NG (1974) Displacement into incubation medium by albumin of highly unsaturated retina free fatty acids arising from membrane lipids. FEBS Lett 40:53–56. [DOI] [PubMed] [Google Scholar]
  • 4. Aveldano MI, Bazan NG (1975) Differential lipid deacylation during brain ischemia in a homeotherm and a poikilotherm. Content and composition of free fatty acids and triacylglycerols. Brain Res 100:99–110. [DOI] [PubMed] [Google Scholar]
  • 5. Aveldano MI, Bazan NG (1977) Acyl groups, molecular species and labeling by 14C glycerol and 3H‐arachidonic acid of vertebrate retina glycerolipids. In: Adv. Exp. Biosynthesis of Lipids, Vol 83, Bazan NG, Brenner RR, Giusto NM, (Eds), pp 397 404, Plenum Press, New York . [DOI] [PubMed] [Google Scholar]
  • 6. Aveldano MI, Bazan NG (1983) Molecular species of phosphatidylcholine, ethanolamine, serine and inositol in microsomal and photoreceptor membranes of bovine retina. J Lipid Res 24:620 627. [PubMed] [Google Scholar]
  • 7. Aveldano MI, Pasquare de Garcia SJ, Bazan NG (1983) Biosynthesis of molecular species of inositol, choline, serine, and ethanolamine glycerophospholipids in the bovine retina. J Lipid Res 24:628 638. [PubMed] [Google Scholar]
  • 8. Bazan NG (1990) Supply of n‐3 polyunsaturated fatty acids and their significance in the central nervous system. In: Nutrition and the Brain, vol. 8, Wurtman RJ, Wurtman JJ (Eds) pp. 1–24, Raven Press, Ltd., New York . [Google Scholar]
  • 9. Bazan NG (2003) Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet‐activating factor. J Lipid Res 44:2221–2233. [DOI] [PubMed] [Google Scholar]
  • 10. Bazan NG, Allan G (1998) Platelet‐activating factor and other bioactive lipids. In: Cerebrovascular Disease: Pathophysiology, Diagnosis, and Management, Ginsberg MD, Bogousslavsky J (Eds), pp. 532–555, Blackwell Science, Inc., Malden , MA . [Google Scholar]
  • 11. Bazan NG, Lukiw WJ (2002) Cyclooxygenase‐2 and presenilin‐1 gene expression induced by interleukin‐1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J Biol Chem 277:30359–30367. [DOI] [PubMed] [Google Scholar]
  • 12. Bazan NG, Rodriguez de Turco EB (1996) Alterations in plasma lipoproteins and DHA transport in progressive rod‐cone degeneration (prcd). In: Retinal Degeneration and Regeneration, Proceedings of an International Symposium in Kanazawa, Japan, July 89, 1995. Kato S, Osborne NN, Tamai M (Eds) pp 89–97, Kugler Publications, Amsterdam , New York . [Google Scholar]
  • 13. Bazan NG, Birkle DL, Reddy TS (1984) Docosahexaenoic acid (22:6, n‐3) is metabolized to lipoxygenase reaction products in the retina. Biochem Biophys Res Commun 125:741–747. [DOI] [PubMed] [Google Scholar]
  • 14. Bazan NG, Birkle DL, Reddy TS (1985) Biochemical and nutritional aspects of the metabolism of polyunsaturated fatty acids and phospholipids in experimental models of retinal degeneration. In: Retinal Degeneration: Experimental and Clinical Studies. LaVail MM, Anderson RE, Hollyfield J (Eds) pp. 159–187, Alan R. Liss, Inc., New York . [Google Scholar]
  • 15. Beal MF (1996) Mitochondria, free radicals and neurodegeneration. Curr Opin Neurol 6:661–666. [DOI] [PubMed] [Google Scholar]
  • 16. Belayev L, Marcheselli VL, Khoutorova L, Rodriguez de Turco EB, Busto R, Ginsberg MD, Bazan NG (2005) Docosahexaenoic acid complexed to albumin elicits high‐grade ischemic neuroprotection. Stroke 36:118–123. [DOI] [PubMed] [Google Scholar]
  • 17. Bicknell IR, Darrow R, Barsalou L, Fliesler SJ, Organisciak DT (2002) Alterations in retinal rod outer segment fatty acids and light‐damage susceptibility in P23H rats. Mol Vis 8:333–340. [PubMed] [Google Scholar]
  • 18. Bryckaert M, Guillonneau X, Hecquet C, Courtois Y, Mascarelli F (1999) Both FGF1 and bcl‐x synthesis are necessary for the reduction of apoptosis in retinal pigmented epithelial cells by FGF2: role of the extracellular signal‐regulated kinase 2. Oncogene 18:7584–7593. [DOI] [PubMed] [Google Scholar]
  • 19. Catalan J, Moriguchi T, Slotnick B, Murthy M, Greiner RS, Salem N Jr (2002) Cognitive deficits in docosahexaenoic acid‐deficient rats. Behav Neurosci 116:1022–1031. [DOI] [PubMed] [Google Scholar]
  • 20. Chatzipanteli K, Alonso OF, Kraydieh S, Dietrich WD (2000) Importance of posttraumatic hypothermia and hyperthermia on the inflammatory response after fluid percussion brain injury: biochemical and immunocytochemical studies. J Cereb Blood Flow Metab 20:531–542. [DOI] [PubMed] [Google Scholar]
  • 21. Choe HG, Anderson RE (1990) Unique molecular species composition of glycerolipids of frog rod outer segments. Exp Eye Res 51:159–165. [DOI] [PubMed] [Google Scholar]
  • 22. Chopp M, Li Y, Zhang RL, Prostak J (1996) Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab 16:578–584. [DOI] [PubMed] [Google Scholar]
  • 23. Gaudet RJ, Levine L (1980) Effect of unilateral common carotid artery occlusion on levels of prostaglandins D2, F2, and 6‐keto‐prostaglandin F1 in gerbil brain. Stroke 11:648–652. [DOI] [PubMed] [Google Scholar]
  • 24. Gordon WC, Rodriguez de Turco EB, Bazan NG (1992) Retinal pigment epithelial cells play a central role in the conservation of docosahexaenoic acid by photoreceptor cells after shedding and phagocytosis. Curr Eye Res 11:73–83. [DOI] [PubMed] [Google Scholar]
  • 25. Hallenbeck JM, Kochanek PM (1998) Inflammatory responses in cerebral ischemia. In: Cerebrovascular Disease: Pathophysiology, Diagnosis, and Management, volume 1. Ginsberg MD, Bogousslavsky J, (Eds.) pp. 489–506, Blackwell Science, Malden , MA . [Google Scholar]
  • 26. Hinton DR, He S, Lopez PF (1998) Apoptosis in surgically excised choroidal neovascular membranes in age‐related macular degeneration. Arch Ophthalmol 116:203–209. [DOI] [PubMed] [Google Scholar]
  • 27. Horrocks LA, Farooqui AA (1994) NMDA receptor‐stimulated release of arachidonic acid: Mechanisms for the Bazan effect. In: Cell Signal Transduction, Second Messengers, and Protein Phosphorylation in Health and Disease, Municio AM, Miras‐Portugal MT, (Eds.) pp. 113–128, Plenum Press, New York , NY . [Google Scholar]
  • 28. Hu J, Bok D (2001) A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol Vis 7:14–19. [PubMed] [Google Scholar]
  • 29. Kim HY, Akbar M, Lau A, Edsall L (2000) Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n–3). Role of phosphatidylserine in anti‐apoptotic effect. J Biol Chem 275:35215–35223. [DOI] [PubMed] [Google Scholar]
  • 30. Li F, Cao W, Anderson RE (2001) Protection of photoreceptor cells in adult rats from light‐induced degeneration by adaptation to bright cyclic light. Exp Eye Res 73:569–577. [DOI] [PubMed] [Google Scholar]
  • 31. Liang YG, Jorgensen AG, Kaestel CG, Wiencke AK, Lui GM, La Cour MH, Ropke CH, Nissen MH (2000) Bcl‐2, Bax, and c‐Fos expression correlates to RPE cell apoptosis induced by UV‐light and daunorubicin. Curr Eye Res 20:25–34. [PubMed] [Google Scholar]
  • 32. Litman BJ, Niu SL, Polozova A, Mitchell DC (2001) The role of docosahexaenoic acid containing phospholipids in modulating G proteincoupled signaling pathways: visual transduction. J Mol Neurosci 16:237–242. [DOI] [PubMed] [Google Scholar]
  • 33. Mabuchi T, Kitagawa K, Ohtsuki T, Kuwabara T, Yagita Y, Yanagihara T, Hori M, Matsumoto M (2000) Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 31:1735–1743. [DOI] [PubMed] [Google Scholar]
  • 34. Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN, Bazan NG (2003) Novel docosanoids inhibit brain ischemia‐reperfusion‐mediated leukocyte infiltration and pro‐inflammatory gene expression. J Biol Chem 278:43807–43817. Erratum in:J Biol Chem (2003) 278:51974. [DOI] [PubMed] [Google Scholar]
  • 35. Matsuo Y, Onodera H, Shiga Y, Nakamura M, Ninomiya M, Kihara T, Kogure K (1994) Correlation between myeloperoxidase quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 25:1469–1475. [DOI] [PubMed] [Google Scholar]
  • 36. Mattson MP, Bazan NG. (2005) Apoptosis and Necrosis. In: 7th ed. Siegel G, Albers RW, Brady S, Price D., (Eds.) London , Elsevier. In press. [Google Scholar]
  • 37. McGeer EG, McGeer PL (2003) Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatr 27:741–749. [DOI] [PubMed] [Google Scholar]
  • 38. Moriguchi T, Salem N Jr. (2003) Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J Neurochem 87:297–309. [DOI] [PubMed] [Google Scholar]
  • 39. Moskovitz MA, Kiwak KJ, Hekimian K, Levine L (1984) Synthesisof compounds with properties of leukotrienes C4 and D4 in gerbil brain after ischemia and reperfusion. Science 224:886–899. [DOI] [PubMed] [Google Scholar]
  • 40. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. (2004) Neuroprotectin D1: a docosahexaenoic acid‐derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A 101:8491–8496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Neuringer M, Connor WE, Van Petten C, Barstad L (1984) Dietary omega‐3 fatty acid deficiency and visual loss in infant rhesus monkeys. J Clin Invest 73:272–276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Neuringer M, Connor WE, Lin DS, Barstad L, Luck S (1986) Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci U S A 83:4021–4025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Nourooz‐Zadeh J, Liu EHC, Yhlen B, Änggård EE, Halliwell B (1999) F4‐isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. J Neurochem 72:734–740. [DOI] [PubMed] [Google Scholar]
  • 44. Organisciak DT, Darrow RM, Jiang YL, Blanks JC (1996) Retinal light damage in rats with altered levels of rod outer segment docosahexaenoate. Invest Ophthalmol Vis Sci 37:2243–2257. [PubMed] [Google Scholar]
  • 45. Osborne NN, Cazevieillem C, Pergandem G, Wood JP (1997) Induction of apoptosis in cultured human retinal pigment epithelial cells is counteracted by flupirtine. Invest Ophthalmol Vis Sci 38:1390–1400. [PubMed] [Google Scholar]
  • 46. Philp NJ, Wang D, Yoon H, Hjelmeland LM (2003) Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE‐19 cells. Invest Ophthalmol Vis Sci 44:1716–1721. [DOI] [PubMed] [Google Scholar]
  • 47. Politi LE, Rotstein NP, Carri NG (2001) Effect of GDNF on neuroblast proliferation and photoreceptor survival: additive protection with docosahexaenoic acid. Invest Ophthalmol Vis Sci 42:3008–3015. [PubMed] [Google Scholar]
  • 48. Radu RA, Mata NL, Nusinowitz S, Liu X, Sieving PA, Travis GH (2003) Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc Natl Acad Sci U S A 100:4742–4747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Reddy TS, Bazan NG (1984) Synthesis of arachidonoyl coenzyme A and docosahexaenoyl coenzyme A in retina. Curr Eye Res 3:1225–1232. [DOI] [PubMed] [Google Scholar]
  • 50. Roberts LJ 2nd, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, Dettbarn WD, Morrow JD (1998) Formation of isoprostane‐like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 273:13605–13612. [DOI] [PubMed] [Google Scholar]
  • 51. Rothwell NJ, Luheshi GN (2000) Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 23:618–625. [DOI] [PubMed] [Google Scholar]
  • 52. Rotstein NP, Politi LE, German OL, Girotti R (2003) Protective effect of docosahexaenoic acid on oxidative stress‐induced apoptosis of retina photoreceptors. Invest Ophthalmol Vis Sci 44:2252–2259. [DOI] [PubMed] [Google Scholar]
  • 53. Royo NC, Wahl F, Stutzmann JM (1999) Kinetics of polymorphonuclear neutrophil infiltration after a traumatic brain injury in rat. NeuroReport 10:1363–1367. [DOI] [PubMed] [Google Scholar]
  • 54. Salem N Jr, Kim HY, Yergey JA (1986) Docoshexaenoic acid: membrane function and metabolism. In: The Health Effects of Polyunsaturated Fatty Acids in Seafoods, Simopoulos AP, Kifer RR, Martin R (Eds). Pp. 263–317, Academic Press, New York , NY . [Google Scholar]
  • 55. Salem N Jr, Litman B, Kim HY, Gawrisch K (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36:945–959. [DOI] [PubMed] [Google Scholar]
  • 56. Scott BL, Bazan NG (1989) Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc Natl Acad Sci U S A 86:2903–2907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K (2000) Novel functional sets of lipid‐derived mediators with antiinflammatory actions generated from omega‐3 fatty acids via cyclooxygenase 2: nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192:1197–1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL (2002) Resolvins: A family of bioactive products of omega‐3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196:1025–1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Sieving PA, Chaudhry P, Kondo M, Provenzano M, Wu D, Carlson TJ, Bush RA, Thompson DA (2001) Inhibition of the visual cycle in vivo by 13‐cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. Proc Natl Acad Sci U S A 98:1835–1840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Simopoulos AP, Leaf A Salem N Jr (1999) Workshop on the essentiality of and recommended dietary intakes for omega‐6 and omega‐3 fatty acids. J Am Coll Nutr 18:487–489. [DOI] [PubMed] [Google Scholar]
  • 61. Sparrow JR, Cai B (2001) Blue light‐induced apoptosis of A2E‐containing RPE: involvement of caspase‐3 and protection by Bcl‐2. Invest Ophthalmol Vis Sci 42:1356–1362. [PubMed] [Google Scholar]
  • 62. Sparrow JR, Vollmer‐Snarr HR, Zhou J, Jang YP, Jockusch S, Itagaki Y, Nakanishi K (2003) A2E‐epoxides damage DNA in retinal pigment epithelial cells. Vitamin E and other antioxidants inhibit A2E‐epoxide formation. J Biol Chem 278:18207–18213. [DOI] [PubMed] [Google Scholar]
  • 63. Stinson AM, Wiegand RD, Anderson RE (1991) Recycling of docosahexaenoic acid in rat retinas during n‐3 fatty acid deficiency. J Lipid Res 32:2009–2017. [PubMed] [Google Scholar]
  • 64. Sun GY, Xu J, Jensen MD, Simonyi A (2004) Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 45:205–213. [DOI] [PubMed] [Google Scholar]
  • 65. Weisinger HS, Armitage JA, Jeffrey BG, Mitchell DC, Moriguchi T, Sinclair AJ, Weisinger RS, Salem N Jr (2002) Retinal sensitivity loss in third‐generation n‐3 PUFA‐deficient rats. Lipids 37:759–765. [DOI] [PubMed] [Google Scholar]
  • 66. Wheeler TG, Benolken RM, Anderson RE (1975) Visual membranes: specificity of fatty acid precursors for the electrical response to illumination. Science 188:1312–1314. [DOI] [PubMed] [Google Scholar]
  • 67. Wiegand RD, Anderson RE (1983) Phospholipid molecular species of frog rod outer segment membranes. Exp Eye Res 37:159–173. [DOI] [PubMed] [Google Scholar]
  • 68. Xu J Chen S, Ahmed SH, Chen H, Ku G, Goldberg MP, Hsu CY (2001) Amyloid‐beta peptides are cytotoxic to oligodendrocytes. J Neurosci 21: RC118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Yavin E, Brand A, Green P (2002) Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress. Nutr Neurosci 5:149–157. [DOI] [PubMed] [Google Scholar]
  • 70. Yoshida S, Harik S, Busto R, Santiso M, Martinez E, Ginsberg MD (1984) Free fatty acids and energy metabolites in ischemic cerebral cortex with noradrenaline depletion. J Neurochem 42:711–717. [DOI] [PubMed] [Google Scholar]
  • 71. Zhang R, Brennan ML, Shen Z, MacPherson JC, Schmitt D, Molenda CE, Hazen SL. (2002) Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 277:46116–46122. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES